





TO THE EDITOR—We read with interest
the article by Sassi et al published in
Clinical Infectious Diseases [1]. They
investigated Pneumocystis jirovecii geno-
types involved in Pneumocystis pneumo-
nia (PCP) outbreaks among renal
transplant recipients. To that aim, they
used fragment length polymorphisms of
the major surface glycoprotein gene
family. This work revealed that the same
P. jirovecii genotype was involved in 2
outbreaks, 1 in Zurich [2] and 1 in
Munich [3], whereas another genotype
was linked to a Japanese outbreak [4]. It
was likely that the most predominant ge-
notype in the area was not involved in
the 2 European outbreaks because un-
linked control cases were infected with
different genotypes. The authors con-
cluded that there may have been an in-
creased virulence of the outbreak
genotypes in renal transplant recipients,
and that the Zurich and Munich out-
breaks may have had a common source
of infection. These observations provid-
ed new insights into the transmission
patterns of this opportunistic pathogen,
but analysis of other outbreaks is needed
in order to better understand the issue
and improve prevention measures.
We reinvestigated the genotypes in-
volved in 2 other PCP outbreaks among
renal transplant recipients that occurred
in Europe – 1 in Frankfurt [5] and 1 in
Lyon [6]. To compare the genotypes of
the different outbreaks, we considered the
most frequently used method of typing,
which is the sequencing of 4 genomic
loci. These loci included the internal
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transcribed spacer 1 of the rRNA operon
[ITS1], the variable region of the mito-
chondrial 26S rRNA gene [mt26], the
intron of the nuclear 26S rRNA gene
[26S], and the β-tubulin intron 6 region
[β-tub]; the Japanese outbreak was not in-
vestigated using this method and thus
could not be compared.
The genotype observed in Frankfurt
was reported to harbor the same alleles as
the genotype involved in the Zurich and
Munich outbreaks for 3 of the 4 loci (B,
7, and 1 for ITS1, mt26, and β-tub, re-
spectively), but a different allele for locus
26S. There was some confusion between 2
close polymorphic positions (296 and
301–305), and after a reassessment of the
sequences of the latter locus, it was
found that the locus was identical in
the 3 outbreaks (with the sequence
TTTTTACTCTT at positions 296 through
306). The genotype involved in the Lyon
outbreak could not be directly compared
because another typing method was origi-
nally used (single-strand conformation
polymorphism of the same 4 genomic
loci). Consequently, we sequenced the 4
loci from the DNA of 3 isolates of this
genotype that we had stored at −20°C.
The results were identical for the 3 iso-
lates, and the genotype proved to be dif-
ferent from that of the Zurich and
Munich outbreaks because it harbored
different alleles for 3 of the 4 loci (B1 and
8 for ITS1 and mt26, respectively, and a
26S allele with TTTTTTACTCT at posi-
tions 296 through 306). Thus, the out-
break genotype was the same in Zurich,
Munich, and Frankfurt, whereas a differ-
ent one was involved in Lyon.
Two epidemiological factors may have
been important in the variation of the
genotype involved in the different out-
breaks: (1) the period of time played a
role, as the Lyon outbreak occurred from
1994 to 1996, whereas the 4 others took
place from 2005 to 2008; (2) the geo-
graphical location is relevant because
Frankfurt, Zurich, and Munich are rela-
tively close cities, whereas Japan is thou-
sands of kilometers away.
Analyses of a large number of PCP
cases showed that the genotype involved
in the Lyon outbreak was one of the
most prevalent during the period in the
area [6], as well as in several European
locations, including Zurich [7]. This ge-
notype might have been preferentially
transmitted during the outbreak because
it has been observed that all suspected
cases of interhuman transmission in-
volved this genotype [6]. A particularity
of the Lyon outbreak was that it involved
not only transplant recipients but also
human immunodeﬁciency virus–infected
patients who mostly served as potential
donors in the suspected transmission
events, with one patient being a recipi-
ent. Thus, the data suggested that the
Lyon outbreak was linked to a predomi-
nant genotype that might be more
virulent and/or more transmissible inde-
pendently of the underlying disease af-
fecting the host. This conclusion differs
from that of Sassi et al [1], which hy-
pothesizes that in renal transplant recipi-
ents, outbreak genotypes are more
virulent but not predominant. Neverthe-
less, as acknowledged by Sassi et al, it
cannot be excluded that typing more iso-
lates from Zurich and Munich may have
revealed that the outbreak genotype was,
in fact, predominant.
In conclusion, our observations provide
additional information suggesting that the
genotypes linked to outbreaks may vary
according to the geographical location as
well as over time. Whether outbreak geno-
types are always predominant and
whether these harbor speciﬁc pathogeni-
city factors remain open questions.
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